(EMAILWIRE.COM, June 08, 2019 ) According to the new market research "Lung Cancer Surgery Market by Procedure (Thoracotomy (Lobectomy, Pneumonectomy, Segmentectomy), Minimally Invasive), Device (Surgical (Clamps, Forceps, Retractors, Stapler), Monitoring (Camera, Trocar), Endoscopic Instrument) - Global Forecast to 2021" published by MarketsandMarkets

Increasing prevalence of lung cancer, rising ageing population, rising awareness about advanced treatment methods are the major driving factors for this market. The base year considered for the study is 2015, and the forecast has been provided for the period between 2016 and 2021.

Don’t miss out on business opportunities in Lung Cancer Surgery Market.
Speak to our analyst and gain crucial industry insights that will help your business grow: https://www.marketsandmarkets.com/speaktoanalyst.asp?id=222

The market is segmented into surgical instruments, monitoring and visualizing systems, and endosurgical equipment. In 2016, the surgical instrument segment is expected to account for the largest share of the market due to increasing prevalence of lung cancer and growing aging population.

Browse and in-depth TOC on “Lung Cancer Surgery Market "
85 – Tables
44 – Figures
135 – Page
Request for Sample Report @ https://www.marketsandmarkets.com/requestsample.asp?id=222

Based on procedure, the market is segmented into thoracotomy and minimally invasive surgeries. The thoracotomy segment further sub segmented into lobectomy, segmentectomy, sleeve resection, and pneumonectomy. The minimally invasive surgeries segment is expected to grow at the highest CAGR during the forecast period due to increasing awareness about early detection of lung cancer and advantages of MIS over conventional surgeries.

Based on region, the market is segmented into North America, Europe, Asia, and the Rest of the World (RoW). In 2016, North America is expected to account for the largest share of the market. Growth in this market is mainly driven by the increasing geriatric population, availability of reimbursement for lung cancer surgeries, increasing number of lung cancer awareness programs, and technological advancements in cancer treatment.

Download an Illustrative overview of the report @ https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=222

Minimally invasive surgeries are more advanced surgical methods than conventional open surgeries. Video-assisted thoracoscopic surgery (VATS) and robotic surgeries are examples of minimally
invasive surgeries. These surgeries are especially carried out to perform lobectomy or segmentectomy procedures for treating lung cancer patients. VATS is a surgical method used for the diagnosis and treatment of lung diseases, especially non-small-cell lung carcinoma. Despite the growing acceptance for VATS resections, this minimally invasive technique has had slow adoption due to concerns regarding oncological principles, costs, possible complications, time spent on learning, and lack of trained expertise for the same. Shorter hospital stays, smaller incisions, and faster recovery are the major driving factors for minimally invasive surgeries. These advantages of minimally invasive surgeries are expected to fuel the market during the forecast period.

Market Players
Key players in the lung cancer surgery market include Ethicon US LLC (U.S.), Intuitive Surgical Inc. (U.S.), Olympus Corporation (Japan), Accuray Inc. (U.S.), AngioDynamics Inc. (U.S.), Teleflex Inc. (U.S.), KARL STORZ GmbH (Germany), Ackermann Instrumente GmbH (Germany), Scanlan International Inc. (U.S.), and Trokamed GmbH (Germany).